ACCESS Newswire
18 Sep 2019, 14:49 GMT+10
SAN DIEGO, CA / ACCESSWIRE / September 18, 2019 / Calidi Biotherapeutics, Inc., a clinical‐stage immuno-oncology company at the forefront of cell-based oncolytic virus immunotherapies for cancer, today announced that they were named one of the '50 Most Trustworthy Companies of the Year" for 2019 by The Silicon Review magazine.
Calidi Biotherapeutics has developed a ground-breaking cell-based technology to overcome the barriers that all oncolytic virus-based cancer treatments face. Their proprietary technology platform has been shown to effectively potentiate oncolytic viruses, using both autologous and scalable allogeneic stem cell-based delivery technology.
'We are honored to be recognized by The Silicon Review magazine as one of the 50 Most Trustworthy Companies of the Year,' said Allan Camaisa, CEO of Calidi Biotherapeutics. 'This is a true testament of the commitment we put behind Calidi Biotherapeutics, and the fact that we always put our most important asset, our people first.'
'A winning a spot on the '50 Most Trustworthy Companies of the Year' for 2019 indicates that Calidi Biotherapeutics has distinguished itself from its peers by proving itself valuable in terms of leadership, reliability, innovation, and market position,' said Vishnu Vardhan Kulkarni, Managing Editor of the Silicon Review magazine.
About Calidi Biotherapeutics
Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology that is revolutionizing the effective delivery of oncolytic viruses for targeted therapy against difficult to treat cancers. Calidi Biotherapeutics is advancing a potent allogeneic stem cell and oncolytic virus combination for use in multiple oncology indications. In addition, our team is developing a universal cell delivery system to house, protect, and potentiate any oncolytic viruses currently in development which can potentially enhance efficacy and improve patient safety. Calidi Biotherapeutics is headquartered in San Diego, California. For more information, please visit www.calidibio.com.
Investor Contact:
Stephen Thesing
Senior Vice President, Corporate Development & Operations
[email protected]
Press Contact:
Aimee Eucce
[email protected]
Calidi Biotherapeutics, Inc.
Related Links
http://www.calidibio.com
SOURCE: Calidi Biotherapeutics
Get a daily dose of Miami Mirror news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Miami Mirror.
More InformationHong Kong: Cathay Pacific Airways is preparing for a slowdown in air cargo traffic between China and the United States as new trade...
SHANGHAI, China: Nissan is making a fresh push to regain its footing in China with a US$1.4 billion investment and a pledge to speed...
TOKYO, Japan: Toyota's Hino Motors and Daimler Truck's Mitsubishi Fuso are edging closer to a long-awaited merger of their truck operations,...
WASHINGTON, D.C.: The United States plans to press India for sweeping changes to its e-commerce policies as part of negotiations aimed...
BEIJING, China: China's automobile exports rose sharply in the first quarter of 2024, with 1.54 million vehicles shipped abroad, marking...
BEIJING, China: At Home Plate BBQ in Beijing, the iconic Texan brisket is about to get a new passport. The restaurant, known for its...
WASHINGTON, D.C.: A nuclear power plant in Michigan is hoping to become the first in the U.S. to restart after being permanently shut...
WASHINGTON, D.C.: This week, the Federal Aviation Administration (FAA) said it is taking steps to stop collisions between helicopters...
THE VATICAN - U.S. President Donald Trump met privately with Ukrainian President Volodymyr Zelenskyy in St. Peter's Basilica in Vatican...
WASHINGTON, D.C.: This week, Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary said they plan to remove artificial...
WASHINGTON, D.C.: The United States plans to press India for sweeping changes to its e-commerce policies as part of negotiations aimed...
LONDON, U.K.: British Prime Minister Keir Starmer and New Zealand Prime Minister Christopher Luxon decided to strengthen their countries'...